NZM2:ETR
Novozymes
€ 58,00
0,00%
(0,00) 1D
7 okt, 17:35:31 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor NZM2 genereren…
Openen
€ 57,42
Hoog
€ 58,00
Laag
€ 57,38
Beursw.
176,50 mld.
Gem. vol.
123,00
Volume
50,00
52 wk hoog
€ 61,96
52 wk laag
€ 46,74
Aantal medewerkers
11K
Openen
€ 57,42
Hoog
€ 58,00
Laag
€ 57,38
Beursw.
176,50 mld.
Gem. vol.
123,00
Volume
50,00
52 wk hoog
€ 61,96
52 wk laag
€ 46,74
Aantal medewerkers
11K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Simply Wall Street
·
1 dag geleden
How Investors Are Reacting To Novonesis Stock As US Dairy Capacity Expands
AD HOC NEWS
·
2 dagen geleden
Novonesis completes MicroBioGen deal as Novonesis stock gains 1.15 percent
Profiel
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Over Novozymes